G Medical Innovations Holdings Ltd. Warrants
GMVDW
GMVDW was delisted on the 22nd of August, 2023.
2 hedge funds and large institutions have $133K invested in G Medical Innovations Holdings Ltd. Warrants in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
428% more capital invested
Capital invested by funds: $25.1K → $133K (+$108K)
100% more funds holding
Funds holding: 1 → 2 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$23.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2 |
GMVDW Hedge Fund Activity: Q2 2023 in Review
2 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Warrants (GMVDW) for Q2 2023, worth a combined $133K — up 428% from $25.1K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new GMVDW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $23.7K. The largest seller was Armistice Capital, cutting an estimated $2.
- 2 institutional investors held G Medical Innovations Holdings Ltd. Warrants (GMVDW) as of Q2 2023, up from 1 in Q1 2023.
- Funds reported $133K of G Medical Innovations Holdings Ltd. Warrants stock for Q2 2023, up 428% quarter-over-quarter.
- 1 fund opened new G Medical Innovations Holdings Ltd. Warrants positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest G Medical Innovations Holdings Ltd. Warrants buyer in Q2 2023 was Citadel Advisors, an estimated $23.7K added.
- The largest G Medical Innovations Holdings Ltd. Warrants seller in Q2 2023 was Armistice Capital, an estimated $2 sold.
Based on aggregated 13F filings for Q2 2023.